FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
04 Nov 2024 11:00 GMT
… -class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce …
Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session
05 Nov 2024 20:08 GMT
… unique approach to treating complex peripheral arterial disease (PAD), enabling physicians to percutaneously …
Wound Care Center in Standish to offer free foot screening
05 Nov 2024 19:14 GMT
… in the legs and feet (peripheral arterial disease or PAD) or patients may …
Semler Scientific, Inc. (NASDAQ:SMLR) Q3 2024 Earnings Call Transcript
05 Nov 2024 13:50 GMT
… in the early diagnosis of peripheral arterial disease or PAD. With a SaaS …
Leg cramps
05 Nov 2024 12:33 GMT
… , such as blood flow problems (peripheral arterial disease), kidney disease, thyroid disease, and …
Plant-Derived Exosome-Like Nanovesicles in Chronic Wound Healing
05 Nov 2024 09:58 GMT
… , Cassina PC. Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound …
R3 Vascular wins FDA IDE for drug-eluting scaffold
04 Nov 2024 22:58 GMT
… treating below-the-knee (BTK) peripheral arterial disease (PAD). With the FDA granting …
Semler Scientific® Reports Third Quarter 2024 Financial Results and Additional Bitcoin Purchases
04 Nov 2024 21:56 GMT
… of cardiovascular diseases, such as peripheral arterial disease (PAD), and Semler Scientific is …
Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024
04 Nov 2024 19:25 GMT
… . FDA clearance for patients with peripheral arterial disease
LAS VEGAS, Nov. 4, 2024 … ;heart-disease/about/peripheral-arterial-disease.html
3 https:/…